Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial

BACKGROUND: Several studies have demonstrated that spironolactone has an anti-albuminuric property in diabetic nephropathy. As an adverse event, spironolactone often induces the elevation of creatinine levels with hypotension and hyperkalemia. Therefore, we aimed to evaluate the efficacy and safety...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Nephrol
Main Authors: Kato, Sawako, Maruyama, Shoichi, Makino, Hirofumi, Wada, Jun, Ogawa, Daisuke, Uzu, Takashi, Araki, Hisazumi, Koya, Daisuke, Kanasaki, Keizo, Oiso, Yutaka, Goto, Motomitsu, Nishiyama, Akira, Kobori, Hiroyuki, Imai, Enyu, Ando, Masahiko, Matsuo, Seiichi
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577308/
https://ncbi.nlm.nih.gov/pubmed/25795029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-015-1106-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados